|
Market Closed -
Euronext Paris
09:25:00 23/10/2026 pm IST
|
After hours 12:20:03 am | |||
| 84.70 EUR | +1.73% |
|
84.50 | -0.24% |
Company Valuation: Eurofins Scientific SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 20,893 | 12,900 | 11,336 | 9,273 | 11,036 | 14,454 | - | - |
| Change | - | -38.26% | -12.13% | -18.2% | 19.02% | 30.97% | - | - |
| Enterprise Value (EV) 1 | 23,132 | 15,739 | 14,041 | 12,269 | 14,677 | 17,894 | 17,544 | 17,276 |
| Change | - | -31.96% | -10.79% | -12.62% | 19.63% | 21.92% | -1.96% | -1.53% |
| P/E | 27.8x | 22.2x | 45.4x | 26.9x | 28x | 27x | 21.5x | 18.2x |
| PBR | 4.49x | 2.7x | 2.24x | 1.73x | 2.56x | 3.05x | 2.76x | 2.53x |
| PEG | - | -1x | -0.8x | 0.7x | 1.3x | 0.7x | 0.8x | 1x |
| Capitalization / Revenue | 3.11x | 1.92x | 1.74x | 1.33x | 1.51x | 1.91x | 1.81x | 1.7x |
| EV / Revenue | 3.44x | 2.34x | 2.16x | 1.77x | 2.01x | 2.37x | 2.2x | 2.03x |
| EV / EBITDA | 12.2x | 10.4x | 10.3x | 7.91x | 8.94x | 10.1x | 9.15x | 8.32x |
| EV / EBIT | 15.7x | 15.2x | 16.7x | 12.1x | 13.6x | 15.7x | 13.9x | 12.4x |
| EV / FCF | 22.8x | 23.2x | 29.6x | 15.3x | 16.7x | 19.2x | 17.6x | 16x |
| FCF Yield | 4.39% | 4.3% | 3.38% | 6.53% | 5.97% | 5.21% | 5.67% | 6.24% |
| Dividend per Share 2 | 1 | 1 | 0.5 | 0.5 | 0.72 | 0.7993 | 0.9128 | 0.96 |
| Rate of return | 0.92% | 1.49% | 0.85% | 1.01% | 1.15% | 0.96% | 1.1% | 1.15% |
| EPS 2 | 3.91 | 3.02 | 1.3 | 1.83 | 2.23 | 3.081 | 3.868 | 4.571 |
| Distribution rate | 25.6% | 33.1% | 38.5% | 27.3% | 32.3% | 25.9% | 23.6% | 21% |
| Net sales 1 | 6,718 | 6,712 | 6,515 | 6,951 | 7,296 | 7,559 | 7,987 | 8,507 |
| EBITDA 1 | 1,902 | 1,513 | 1,364 | 1,552 | 1,641 | 1,769 | 1,918 | 2,076 |
| EBIT 1 | 1,473 | 1,037 | 842 | 1,017 | 1,079 | 1,140 | 1,264 | 1,392 |
| Net income 1 | 783 | 606 | 310 | 406 | 475 | 545.2 | 672.6 | 831 |
| Net Debt 1 | 2,239 | 2,839 | 2,705 | 2,996 | 3,641 | 3,440 | 3,090 | 2,822 |
| Reference price 2 | 108.80 | 67.06 | 58.98 | 49.31 | 62.40 | 83.26 | 83.26 | 83.26 |
| Nbr of stocks (in thousands) | 1,92,035 | 1,92,365 | 1,92,194 | 1,88,049 | 1,76,864 | 1,73,599 | - | - |
| Announcement Date | 22/02/22 | 01/03/23 | 27/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.03x | 2.37x | 10.12x | 0.96% | 1.62TCr | |
| 18.38x | 6.48x | 12.88x | 1.62% | 6.33TCr | |
| 30.22x | 7.94x | 26.49x | 0.05% | 5.49TCr | |
| 36.58x | 6.5x | 19.41x | 0.88% | 5.33TCr | |
| 35.46x | 3.44x | 14.83x | -.--% | 4.58TCr | |
| 50.32x | 5.82x | 31.95x | -.--% | 4.35TCr | |
| -19.48x | 188.5x | -20.74x | -.--% | 4.02TCr | |
| 29.02x | 8.23x | 21.28x | 0.37% | 3.35TCr | |
| 27.38x | 5.77x | 14.95x | -.--% | 2.37TCr | |
| 32.79x | 5.99x | 20.16x | -.--% | 2.38TCr | |
| Average | 26.77x | 24.10x | 15.13x | 0.39% | 3.98TCr | |
| Weighted average by Cap. | 26.72x | 24.56x | 15.69x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ERF Stock
- Valuation Eurofins Scientific SE
Select your edition
All financial news and data tailored to specific country editions
